TRIF mobilizes unique primary defense against gram-negative bacteria in intestinal interface

Gut Microbes

Volumn 3, Issue 5, 2012, Pages 437-441

  Sotolongo, John ^a   Kanagavelu, Saravana ^a   Hyun, Jinhee ^a   Ruiz, Jose ^a   Fukata, Masayuki ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Host defense mechanism; Host pathogen interactions; Infection; Innate immunity; Intestine; Macrophages; Mucosal immunology

Indexed keywords

BETA INTERFERON; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; IMMUNITY; INTESTINE; MACROPHAGE; MACROPHAGE ACTIVATION; MESENTERY LYMPH NODE; NONHUMAN; SIGNAL TRANSDUCTION; YERSINIA ENTEROCOLITICA; ANIMAL; GASTROINTESTINAL TRACT; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOGENICITY; SPLEEN;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; YERSINIA ENTEROCOLITICA;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; GASTROINTESTINAL TRACT; LIVER; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 4; YERSINIA ENTEROCOLITICA;

EID: 85046981945     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.20873     Document Type: Article

References (32)

1. Griffin AJ, McSorley SJ. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol 2011; 4:371-82; PMID:21307847; http://dx.doi.org/10.1038/mi.2011.2.
2. Sotolongo J, Ruiz J, Fukata M. The role of innate immunity in the host defense against intestinal bacterial pathogens. Curr Infect Dis Rep 2012; 14:15-23; PMID:22139594; http://dx.doi.org/10.1007/s11908-011-0234-4.
3. Arnold R, Jehl A, Rattei T. Targeting effectors: the molecular recognition of Type III secreted proteins. Microbes Infect 2010; 12:346-58; PMID:20178857; http://dx.doi.org/10.1016/j.micinf.2010.02.003.
4. Mijares LA, Wangdi T, Sokol C, Homer R, Medzhitov R, Kazmierczak BI. Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J Immunol 2011; 186:7080-8; PMID:21572023; http://dx.doi.org/10.4049/jimmunol.1003687.
5. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 2004; 172:3377-81; PMID:15004134.
6. Cai S, Batra S, Shen L, Wakamatsu N, Jeyaseelan S. Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol 2009; 183:6629-38; PMID:19846873; http://dx.doi.org/10.4049/jimmunol.0901033.
7. Jeyaseelan S, Young SK, Fessler MB, Liu Y, Malcolm KC, Yamamoto M, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFNbeta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J Immunol 2007; 178:3153-60; PMID:17312163.
8. Sun Y, Karmakar M, Roy S, Ramadan RT, Williams SR, Howell S, et al. TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways. J Immunol 2010; 185:4272-83; PMID:20826748; http://dx.doi.org/10.4049/jimmunol.1000874.
9. Packiam M, Wu H, Veit SJ, Mavrogiorgos N, Jerse AE, Ingalls RR. Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice. Mucosal Immunol 2012; 5:19-29; PMID:21937985; http://dx.doi.org/10.1038/mi.2011.38.
10. Fischer H, Yamamoto M, Akira S, Beutler B, Svanborg C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 2006; 36:267-77; PMID:16385628; http://dx.doi.org/10.1002/eji.200535149.
11. Sotolongo J, España C, Echeverry A, Siefker D, Altman N, Zaias J, et al. Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. J Exp Med 2011; 208:2705-16; PMID:22124111; http://dx.doi.org/10.1084/jem.20110547.
12. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med 2006; 34:461-70; PMID:16424729; http://dx.doi.org/10.1097/01.CCM.0000198527.71819.E1.
13. O'Brien AD, Rosenstreich DL. Genetic control of the susceptibility of C3HeB/FeJ mice to Salmonella typhimurium is regulated by a locus distinct from known salmonella response genes. J Immunol 1983; 131:2613-5; PMID:6358350.
14. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 2004; 172:6202-8; PMID:15128808.
15. Talbot S, Tötemeyer S, Yamamoto M, Akira S, Hughes K, Gray D, et al. Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance. Immunology 2009; 128:472-83; PMID:19930040; http://dx.doi.org/10.1111/j.1365-2567.2009.03146.x.
16. Feng D, Chen H, Yang KX, Fang F. Pre-peritoneal lipoleiomyoma with hyperoestrogenism in a postmenopausal woman. J Obstet Gynaecol 2011; 31:556-7; PMID:21823874; http://dx.doi.org/10.3109/01443615.2011.578777.
17. Kelly-Scumpia KM, Scumpia PO, Delano MJ, Weinstein JS, Cuenca AG, Wynn JL, et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J Exp Med 2010; 207:319-26; PMID:20071504; http://dx.doi.org/10.1084/jem.20091959.
18. Power MR, Li B, Yamamoto M, Akira S, Lin TJ. A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFNbeta in the host response to Pseudomonas aeruginosa lung infection in mice. J Immunol 2007; 178:3170-6; PMID:17312165.
19. Wiersinga WJ, Wieland CW, Roelofs JJ, van der Poll T. MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One 2008; 3:3494; PMID:18946505; http://dx.doi.org/10.1371/journal.pone.0003494.
20. Wieland CW, Florquin S, Maris NA, Hoebe K, Beutler B, Takeda K, et al. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung. J Immunol 2005; 175:6042-9; PMID:16237099.
21. Bowen WS, Minns LA, Johnson DA, Mitchell TC, Hutton MM, Evans JT. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist. Sci Signal 2012; 5:13; PMID:22337809; http://dx.doi.org/10.1126/scisignal.2001963.
22. Weiss DS, Raupach B, Takeda K, Akira S, Zychlinsky A. Toll-like receptors are temporally involved in host defense. J Immunol 2004; 172:4463-9; PMID:15034062.
23. Sing A, Tvardovskaia N, Rost D, Kirschning CJ, Wagner H, Heesemann J. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int J Med Microbiol 2003; 293:341-8; PMID:14695062; http://dx.doi.org/10.1078/1438-4221-00277.
24. Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, Deng W, et al. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun 2006; 74:2522-36; PMID:16622187; http://dx.doi.org/10.1128/IAI.74.5.2522-36.2006.
25. Asquith MJ, Boulard O, Powrie F, Maloy KJ. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology 2010; 139:519-29.
26. Keestra AM, Godinez I, Xavier MN, Winter MG, Winter SE, Tsolis RM, et al. Early MyD88-dependent induction of interleukin-17A expression during Salmonella colitis. Infect Immun 2011; 79:3131-40; PMID:21576324; http://dx.doi.org/10.1128/IAI.00018-11.
27. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, et al. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 2011; 6:20953; PMID:21698299; http://dx.doi.org/10.1371/journal.pone.0020953.
28. Westphal S, Lügering A, von Wedel J, von Eiff C, Maaser C, Spahn T, et al. Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo. Am J Pathol 2008; 172:671-80; PMID:18258848; http://dx.doi.org/10.2353/ajpath.2008.070393.
29. Oellerich MF, Jacobi CA, Freund S, Niedung K, Bach A, Heesemann J, et al. Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect Immun 2007; 75:3802-11; PMID:17562774; http://dx.doi.org/10.1128/IAI.00419-07.
30. Jepson MA, Clark MA. The role of M cells in Salmonella infection. Microbes Infect 2001; 3:1183-90; PMID:11755406; http://dx.doi.org/10.1016/S1286-4579(01)01478-2.
31. Handley SA, Dube PH, Revell PA, Miller VL. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect Immun 2004; 72:1645-56; PMID:14977972; http://dx.doi.org/10.1128/IAI.72.3.1645-56.2004.
32. Monack DM, Hersh D, Ghori N, Bouley D, Zychlinsky A, Falkow S. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J Exp Med 2000; 192:249-58; PMID:10899911; http://dx.doi.org/10.1084/jem.192.2.249.